Developer docs
API playgroundTry for free, no card

Search company profiles

Reviticell Holdings

Full company profile

uuid0004tqf

Namestring
Reviticell Holdings
Websiteurl
reviticell.com
Company typeenum
Private
Founded yearint
2011
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersJacksonville, United States
HQ citystring
Jacksonville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
regenerative medicine devices, medical device kits, cellular therapy products, regenerative procedure tools, medical device manufacturing
Industry1 code
PRIMARYHLAHALAE
Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Regenerative Medicine Medical Devices
Cost components5 values
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Reviticell Holdings develops and supplies Reviticell Kits, described as highly scalable medical devices intended to make regenerative medical procedures more efficient. The kits are positioned as physical medical device products intended for clinical use by healthcare providers performing regenerative therapies.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Reviticell Kits
CategoryRegenerative Medicine Medical Devices
No data
Peers10 records
TypeBroad incumbent
Description

Global orthopedic device leader with the Angel concentrated-BMC/PRP kit family — the closest scaled incumbent addressing the same point-of-care regenerative-kit need Reviticell targets.

TypeDirect peer
Description

Acquired by Crown Laboratories, Emcyte is best known for point-of-care PRP and cell-concentrate kits used in regenerative procedures — a direct category analogue to the Reviticell Kit concept.

3Regen Lab
TypeDirect peer
Description

Swiss developer of the Cellular Matrix and RegenKit lines for point-of-care preparation of PRP and cell-concentrate therapies; competes in the same 'scalable regenerative kit' niche.

TypeDirect peer
Description

Producer of bone-marrow aspirate concentrate systems and orthobiologic kits used in regenerative orthopedic procedures — overlapping directly with Reviticell's stated value proposition.

TypeBroad incumbent
Description

Public regenerative-medicine company (Apligraf, Dermagraft, NuShield) serving wound care and surgical applications — a broader regenerative-device peer to Reviticell's regenerative-procedure thesis.

TypeBroad incumbent
Description

Public regenerative medicine company built on dehydrated amniotic membrane and other tissue platforms used in wound and surgical healing — broad incumbent in the regenerative-device category.

TypeBroad incumbent
Description

Public regenerative-medicine company behind MACI and Epicel — operates in autologous cell-based regenerative therapies addressing sports medicine and burn applications adjacent to Reviticell's focus.

TypeBroad incumbent
Description

Diversified medical-device platform with a regenerative tissue technologies franchise (Integra dermal regeneration templates) — relevant broader incumbent in regenerative wound and surgical products.

TypeBroad incumbent
Description

Global medical-device company with significant wound-care and orthobiologics portfolios that overlap with the regenerative-procedure category Reviticell is targeting.

TypeBroad incumbent
Description

Large diversified medical-device company with regenerative and sports-medicine offerings (including biologics and platelet-processing kits used in orthopedic surgery).

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Reviticell Holdings

Regenerative Medicine Medical Devicesreviticell.com

Reviticell Holdings firmographics

Firmographics
Name
Reviticell Holdings
Website
https://reviticell.com
Company type
Private
Founded year
2011
Headcount range
1–10 employees
Ownership category
akta.pro rank

Reviticell Holdings industry classification

Industry
Product category
Regenerative Medicine Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHALAE
Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Wound Care, Ostomy & Continence Products

Keywords

  • Regenerative medicine devices
  • Medical device kits
  • Cellular therapy products
  • Regenerative procedure tools
  • Medical device manufacturing

Where Reviticell Holdings is headquartered

Location

Headquarters

HQ city
Jacksonville
HQ country
United States
HQ region
North America

Markets served

Reviticell Holdings business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Reviticell Holdings product offering

Product offering

Core offering

Reviticell Holdings develops and supplies Reviticell Kits, described as highly scalable medical devices intended to make regenerative medical procedures more efficient. The kits are positioned as physical medical device products intended for clinical use by healthcare providers performing regenerative therapies.

Differentiator

Problem solved

Functional benefit

Products and services

  • Reviticell Kits

Companies that use Reviticell Holdings

Customer profile

Ideal customer profiles1 record

Reviticell Holdings technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Reviticell Holdings competitors and assessment

Company assessment

Broad incumbents

  • Arthrex: Global orthopedic device leader with the Angel concentrated-BMC/PRP kit family — the closest scaled incumbent addressing the same point-of-care regenerative-kit need Reviticell targets.
  • Organogenesis: Public regenerative-medicine company (Apligraf, Dermagraft, NuShield) serving wound care and surgical applications — a broader regenerative-device peer to Reviticell's regenerative-procedure thesis.
  • MiMedx: Public regenerative medicine company built on dehydrated amniotic membrane and other tissue platforms used in wound and surgical healing — broad incumbent in the regenerative-device category.
  • Vericel: Public regenerative-medicine company behind MACI and Epicel — operates in autologous cell-based regenerative therapies addressing sports medicine and burn applications adjacent to Reviticell's focus.
  • Integra LifeSciences: Diversified medical-device platform with a regenerative tissue technologies franchise (Integra dermal regeneration templates) — relevant broader incumbent in regenerative wound and surgical products.
  • Smith & Nephew: Global medical-device company with significant wound-care and orthobiologics portfolios that overlap with the regenerative-procedure category Reviticell is targeting.
  • Stryker: Large diversified medical-device company with regenerative and sports-medicine offerings (including biologics and platelet-processing kits used in orthopedic surgery).

Direct peers

  • Emcyte Corporation (Crown Laboratories): Acquired by Crown Laboratories, Emcyte is best known for point-of-care PRP and cell-concentrate kits used in regenerative procedures — a direct category analogue to the Reviticell Kit concept.
  • Regen Lab: Swiss developer of the Cellular Matrix and RegenKit lines for point-of-care preparation of PRP and cell-concentrate therapies; competes in the same 'scalable regenerative kit' niche.
  • Isto Biologics: Producer of bone-marrow aspirate concentrate systems and orthobiologic kits used in regenerative orthopedic procedures — overlapping directly with Reviticell's stated value proposition.

Market position

Customer concentration

Reviticell Holdings social profiles

Digital presence

Reviticell Holdings financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Reviticell Holdings leadership team

Management profile

Number of profiles

Profiles8 records

Reviticell Holdings funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Reviticell Holdings M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Reviticell Holdings

What does Reviticell Holdings do?

Reviticell Holdings develops and supplies Reviticell Kits, described as highly scalable medical devices intended to make regenerative medical procedures more efficient. The kits are positioned as physical medical device products intended for clinical use by healthcare providers performing regenerative therapies.

When was Reviticell Holdings founded?

Reviticell Holdings was founded in 2011. It employs 1 to 10 people.

Where is Reviticell Holdings based?

Reviticell Holdings is headquartered in Jacksonville, United States, in the North America region.

Who are Reviticell Holdings's main competitors?

Broad incumbents on record are Arthrex, Organogenesis, MiMedx, Vericel, Integra LifeSciences, Smith & Nephew and Stryker. Direct peers are Emcyte Corporation (Crown Laboratories), Regen Lab and Isto Biologics.

Does Reviticell Holdings have an API?

No public API is recorded for Reviticell Holdings.

What industry is Reviticell Holdings in?

Reviticell Holdings's product category is Regenerative Medicine Medical Devices. Its primary akta.pro industry code is HLAHALAE, Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts). Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales